Finance

Lists
4886:TYO
ASKA Pharmaceutical Holdings Co Ltd
2 010,00 JP¥
-0,99%
(-20,00) 1D
5-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4886...
Open
2 030 JP¥
High
2 044 JP¥
Low
2 002 JP¥
Mkt. cap
57,81 млд
Avg. vol.
57,84 миң
Volume
56,60 миң
Dividend
2,99%
Quarterly dividend
15 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
12,11
52-wk high
3 045 JP¥
52-wk low
1 917 JP¥
EPS
166 JP¥
No. of employees
2 миң
Open
2 030 JP¥
High
2 044 JP¥
Low
2 002 JP¥
Mkt. cap
57,81 млд
Avg. vol.
57,84 миң
Volume
56,60 миң
Dividend
2,99%
Quarterly dividend
15 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
12,11
52-wk high
3 045 JP¥
52-wk low
1 917 JP¥
EPS
166 JP¥
No. of employees
2 миң
News stories
From web sources and news partners
About ASKA Pharmaceutical Holdings Co Ltd
CEO-
Employees1,61 миң
Founded2021-ж., 1-апр.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
15,93 млд
19,23 млд
16,64 млд
17,38 млд
Cost of goods sold
7,58 млд
9,89 млд
8,82 млд
9,30 млд
Cost of revenue
7,58 млд
9,89 млд
8,82 млд
9,30 млд
Research and development expenses
-
-
7,06 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,18 млд
7,08 млд
-140,00 млн
7,38 млд
Operating expense
7,18 млд
7,08 млд
6,90 млд
7,38 млд
Total operating expenses
14,76 млд
16,97 млд
15,72 млд
16,67 млд
Operating income
1,17 млд
2,26 млд
922,00 млн
712,00 млн
Other non operating income
83,00 млн
-24,00 млн
54,00 млн
67,00 млн
EBT including unusual items
1,04 млд
2,19 млд
2,04 млд
817,00 млн
EBT excluding unusual items
1,11 млд
2,12 млд
811,00 млн
817,00 млн
Income tax expense
2,00 млн
546,00 млн
445,00 млн
284,00 млн
Effective tax rate
0,19%
24,90%
21,80%
34,76%
Other operating expenses
-
-
-
-
Net income
982,00 млн
1,68 млд
1,52 млд
533,00 млн
Net profit margin
6,16%
8,72%
9,13%
3,07%
Earnings per share
-
-
-
-
Interest and investment income
-
164,00 млн
30,00 млн
194,00 млн
Interest expense
-88,00 млн
-53,00 млн
-60,00 млн
-93,00 млн
Net interest expenses
-88,00 млн
111,00 млн
-30,00 млн
101,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,89 млд
-
1,69 млд
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору